@sophierimbaud.bsky.social
CEO of Oselys, passionate about biotech, innovation, and the therapies of tomorrow. We support biotech, medtech & healthtech companies with their strategic, operational, and scientific development.
Fascinating insights on exosomes! These tiny messengers are reshaping our understanding of cancer spread and early diagnosis. Could they be the key to stopping metastasis before it starts, or do we need to tread carefully? Let’s discuss!
#canceresearch #exosomes #biotech
#canceresearch #exosomes #biotech
Exosomes: the future of cancer medicine or a double-edged sword? These tiny vesicles shape the tumor microenvironment, aiding metastasis but also offering potential for early diagnosis. Can we harness them for therapy, or should we be cautious?
#cancerresearch #biotech #exosomes
#cancerresearch #biotech #exosomes
Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation
Pancreatic cancer (PC) is one of the most malignant solid cancers, and PC metastasis, particularly liver metastasis, is a major cause of cancer mortal…
www.sciencedirect.com
March 7, 2025 at 3:34 PM
Fascinating insights on exosomes! These tiny messengers are reshaping our understanding of cancer spread and early diagnosis. Could they be the key to stopping metastasis before it starts, or do we need to tread carefully? Let’s discuss!
#canceresearch #exosomes #biotech
#canceresearch #exosomes #biotech
Exciting to be working on transformative breakthroughs in gene therapy like StitchR show how RNA technology is overcoming the challenge of treating large gene diseases.Big genes are no longer an obstacle our future in personalized medicine just got brighter
#biotech #RNA #duchenne #oselys #dystrophy
#biotech #RNA #duchenne #oselys #dystrophy
New Discovery Enables Gene Therapy for Muscular Dystrophies, Other Disorders
Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size. The genes that are dysfunctional in muscular dystrophi...
www.urmc.rochester.edu
February 3, 2025 at 8:00 AM
Exciting to be working on transformative breakthroughs in gene therapy like StitchR show how RNA technology is overcoming the challenge of treating large gene diseases.Big genes are no longer an obstacle our future in personalized medicine just got brighter
#biotech #RNA #duchenne #oselys #dystrophy
#biotech #RNA #duchenne #oselys #dystrophy
New research in Nature Microbiology reveals how diet shapes the gut microbiome, with omnivores, vegetarians, and vegans each having unique microbial signatures. Could personalized nutrition based on the microbiome be the future of health? Thoughts? #Microbiome #innov
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals - Nature Microbiology
Using 21,561 individuals, the authors present a cross-sectional study of how gut microbiome signatures are associated with dietary intake patterns and with host health outcomes.
www.nature.com
January 29, 2025 at 10:20 AM
New research in Nature Microbiology reveals how diet shapes the gut microbiome, with omnivores, vegetarians, and vegans each having unique microbial signatures. Could personalized nutrition based on the microbiome be the future of health? Thoughts? #Microbiome #innov
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Accelerating biotech innovation with tailored, cost-effective solutions! Oselys helps you scale with streamlined operations, expert project coordination, and impactful commercial strategies. Let’s drive your growth together.
Contact us to learn more!
#biotech #growth #oselys #innovativetherapy
Contact us to learn more!
#biotech #growth #oselys #innovativetherapy
January 23, 2025 at 10:49 AM
Accelerating biotech innovation with tailored, cost-effective solutions! Oselys helps you scale with streamlined operations, expert project coordination, and impactful commercial strategies. Let’s drive your growth together.
Contact us to learn more!
#biotech #growth #oselys #innovativetherapy
Contact us to learn more!
#biotech #growth #oselys #innovativetherapy
𝐀𝐈, 𝐭𝐡𝐞 𝐫𝐢𝐬𝐢𝐧𝐠 𝐬𝐭𝐚𝐫 𝐨𝐟 𝐟𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐢𝐧𝐠… 𝐛𝐮𝐭 𝐚𝐭 𝐰𝐡𝐚𝐭 𝐜𝐨𝐬𝐭?
€7.8B raised in France in 2024, with generative AI leading the way (+46%). Meanwhile, sectors like GreenTech (-29%) or health are struggling.
Are we seeing a worrying imbalance in investment priorities?
#greentech #healthtech #Investment
€7.8B raised in France in 2024, with generative AI leading the way (+46%). Meanwhile, sectors like GreenTech (-29%) or health are struggling.
Are we seeing a worrying imbalance in investment priorities?
#greentech #healthtech #Investment
January 20, 2025 at 2:53 PM
𝐀𝐈, 𝐭𝐡𝐞 𝐫𝐢𝐬𝐢𝐧𝐠 𝐬𝐭𝐚𝐫 𝐨𝐟 𝐟𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐢𝐧𝐠… 𝐛𝐮𝐭 𝐚𝐭 𝐰𝐡𝐚𝐭 𝐜𝐨𝐬𝐭?
€7.8B raised in France in 2024, with generative AI leading the way (+46%). Meanwhile, sectors like GreenTech (-29%) or health are struggling.
Are we seeing a worrying imbalance in investment priorities?
#greentech #healthtech #Investment
€7.8B raised in France in 2024, with generative AI leading the way (+46%). Meanwhile, sectors like GreenTech (-29%) or health are struggling.
Are we seeing a worrying imbalance in investment priorities?
#greentech #healthtech #Investment
Excited to join Bluesky! @oselys, we’re passionate about biotech & innovative therapies. This platform offers new ways to share insights, connect with professionals, and drive innovation. Follow us for the latest in biotech & healthtech!
#innovation #biotech #Bluesky #oselys
#innovation #biotech #Bluesky #oselys
January 20, 2025 at 9:12 AM
Excited to join Bluesky! @oselys, we’re passionate about biotech & innovative therapies. This platform offers new ways to share insights, connect with professionals, and drive innovation. Follow us for the latest in biotech & healthtech!
#innovation #biotech #Bluesky #oselys
#innovation #biotech #Bluesky #oselys